Vice President for External Affairs at the Biotechnology Innovation Organization (BIO) and serves as the Executive Director for the Council of State Bioscience Associations (CSBA). BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and over 30 countries around the world.  As the leader of CSBA, a confederation of state-based, non- profit trade organizations each governed by its own board of directors, she works to advance their mission to promote public understanding of and advocate for public policies that support the responsible development of the bioscience industry.

Ms. Oshman joined BIO in January 2020 after a successful 18-year career at Eli Lilly and Company, where she led federal advocacy outreach. She started her career as a clinical neuroscience researcher and served in multiple clinical development and corporate leadership roles. She earned a Six Sigma Black Belt in 2005 and led multiple transformational efforts across the company before joining the advocacy team in 2007.

From 2012-2014, she served as Chair of the Biotechnology Innovation Organization Alliance Committee and held the same position with the PhRMA Alliance Development Section from 2015-2016. She chaired the Arthritis Foundation Industry Forum from 2014 – 2016, and currently co-chairs the Lupus Foundation of America corporate council. As well, she serves on the corporate advisory councils for a portfolio of national advocacy organizations.

Ms. Oshman also serves on the Board of Directors for the National Alliance for Caregiving and Capital Clubhouse, a Washington DC community mental health agency, which provides psychosocial, vocational, and housing support for people struggling with severe persistent mental illnesses.

Ms. Oshman graduated from American University with a dual degree in Political Science and Communications.

Vice President, External Affairs
Biotechnology Innovation Organization (BIO)